Westfield Capital Management CO LP Alnylam Pharmaceuticals, Inc. Transaction History
Westfield Capital Management CO LP
- $21.6 Billion
- Q4 2024
A detailed history of Westfield Capital Management CO LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Westfield Capital Management CO LP holds 216,126 shares of ALNY stock, worth $59.2 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
216,126Holding current value
$59.2 Million% of portfolio
0.24%Shares
10 transactions
Others Institutions Holding ALNY
# of Institutions
666Shares Held
109MCall Options Held
1.23MPut Options Held
1.18M-
Capital World Investors Los Angeles, CA16.5MShares$4.52 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.49 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.62 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.44 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.36 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.7B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...